{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:59:14Z","timestamp":1792112354220,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Papillomavirus Research"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.pvr.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T23:09:18Z","timestamp":1456873758000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Clinical and analytical performance of the BD Onclarity\u2122 HPV assay for detection of CIN2+ lesions on SurePath samples"],"prefix":"10.1016","volume":"2","author":[{"given":"Ditte M\u00f8ller","family":"Ejegod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Junge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Franzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Bottari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Teresa","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4853-6747","authenticated-orcid":false,"given":"Jesper","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pvr.2016.01.003_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers-a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.pvr.2016.01.003_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.pvr.2016.01.003_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.pvr.2016.01.003_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect.: Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"issue":"7","key":"10.1016\/j.pvr.2016.01.003_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/bjc.2011.326","article-title":"HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study","volume":"105","author":"Kelly","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"Suppl 5","key":"10.1016\/j.pvr.2016.01.003_bib7","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.pvr.2016.01.003_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/apm.12279","article-title":"Cervical cancer screening at crossroads","volume":"122","author":"Lynge","year":"2014","journal-title":"APMIS: Acta Pathol., Microbiol. Et. Immunol. Scand."},{"issue":"4","key":"10.1016\/j.pvr.2016.01.003_bib9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.pvr.2016.01.003_bib10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.pvr.2016.01.003_bib11","doi-asserted-by":"crossref","first-page":"184 e181","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.pvr.2016.01.003_bib12","doi-asserted-by":"crossref","first-page":"46 e41","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am. Journal. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.pvr.2016.01.003_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cyt.12083","article-title":"Understanding HPV tests and their appropriate applications","volume":"24","author":"Cubie","year":"2013","journal-title":"Cytopathology"},{"issue":"10","key":"10.1016\/j.pvr.2016.01.003_bib14","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/JCM.01366-15","article-title":"Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework","volume":"53","author":"Cuschieri","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.pvr.2016.01.003_bib15","article-title":"Clinical validation of the BD Onclarity HPV assay using a non-inferior test","author":"Ejegod","year":"2013","journal-title":"J. Med. Microbiol. Diagn."},{"issue":"4","key":"10.1016\/j.pvr.2016.01.003_bib16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1582-4934.2007.00073.x","article-title":"Comparison of MY09\/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types","volume":"11","author":"Depuydt","year":"2007","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.pvr.2016.01.003_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2013.06.027","article-title":"Cervical cancer screening: which HPV test should be used-L1 or E6\/E7?","volume":"170","author":"Tjalma","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.pvr.2016.01.003_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"19","key":"10.1016\/j.pvr.2016.01.003_bib19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.pvr.2016.01.003_bib20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev.: Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"issue":"7","key":"10.1016\/j.pvr.2016.01.003_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"1\u20132","key":"10.1016\/j.pvr.2016.01.003_bib22","first-page":"61","article-title":"A real-time PCR assay for HPV52 detection and viral load quantification","volume":"58","author":"Onyekwuluje","year":"2012","journal-title":"Clin. Lab."},{"issue":"1","key":"10.1016\/j.pvr.2016.01.003_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1309\/AJCP53KMHNRDICBL","article-title":"Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens","volume":"142","author":"Wright","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.pvr.2016.01.003_bib25","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/JCM.00422-11","article-title":"Evaluation of a new DNA test for detection of carcinogenic human papillomavirus","volume":"49","author":"Castle","year":"2011","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.pvr.2016.01.003_bib26","first-page":"1394","article-title":"Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types","volume":"11","author":"Castle","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev.: Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"issue":"8","key":"10.1016\/j.pvr.2016.01.003_bib27","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00824-08","article-title":"Human papillomavirus genotype specificity of hybrid capture 2","volume":"46","author":"Castle","year":"2008","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"10.1016\/j.pvr.2016.01.003_bib28","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/JCM.02078-05","article-title":"Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+\/6+ PCR method in a population-based cervical screening program","volume":"44","author":"Hesselink","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.pvr.2016.01.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2013.01.018","article-title":"Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities","author":"Mesher","year":"2013","journal-title":"Eur. J Cancer"}],"container-title":["Papillomavirus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852116000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852116000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:02:19Z","timestamp":1762513339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405852116000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":27,"alternative-id":["S2405852116000033"],"URL":"https:\/\/doi.org\/10.1016\/j.pvr.2016.01.003","relation":{},"ISSN":["2405-8521"],"issn-type":[{"value":"2405-8521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and analytical performance of the BD Onclarity\u2122 HPV assay for detection of CIN2+ lesions on SurePath samples","name":"articletitle","label":"Article Title"},{"value":"Papillomavirus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pvr.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}